Patents by Inventor Piotr Swiderski

Piotr Swiderski has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20250061980
    Abstract: Methods, systems, and apparatus, including computer programs encoded on a computer storage medium, for generating data defining molecules. In one aspect, there is provided a method performed by one or more computers, the method comprising: receiving, from a user, a request to generate data identifying candidate molecules satisfying one or more molecular criteria; generating a collection of candidate molecules that satisfy the one or more molecular criteria; generating, for each candidate molecule in the collection of candidate molecules, one or more molecular scores that characterize one or more properties of the candidate molecule; filtering the collection of candidate molecules, based on the molecular scores, to remove a plurality of candidate molecules from the collection of candidate molecules; and after filtering the collection of candidate molecules based on the molecular scores, providing a representation of the collection of candidate molecules to the user.
    Type: Application
    Filed: October 30, 2024
    Publication date: February 20, 2025
    Inventors: Ben Sklaroff, Matteus Jiawei Pan, Korrawat Pruegsanusak, Alexander Upjohn Beatson, Zachary Joseph Kagin, Wojciech Piotr Swiderski, Euxhen Hasanaj, Kenneth Knute Leidal, Anders Joseph Papitto, Maruan Al-Shedivat
  • Patent number: 12230367
    Abstract: Methods, systems, and apparatus, including computer programs encoded on a computer storage medium, for generating data defining molecules. In one aspect, there is provided a method comprising: receiving, from a user, data defining a chemical computation graph, wherein: the chemical computation graph comprises a set of chemical computation nodes and a set of edges; each chemical computation node is configured to perform operations comprising: receiving a set of input molecules; and processing the set of input molecules, in accordance with a sequence of one or more transformation operations associated with the chemical computation node, to generate a set of output molecules; and each edge connects a respective first chemical computation node to a respective second chemical computation node; and generating a set of candidate molecules using the chemical computation graph.
    Type: Grant
    Filed: January 9, 2024
    Date of Patent: February 18, 2025
    Assignee: Genesis Therapeutics, Inc.
    Inventors: Ben Sklaroff, Matteus Jiawei Pan, Korrawat Pruegsanusak, Zachary Joseph Kagin, Wojciech Piotr Swiderski
  • Patent number: 12159693
    Abstract: Methods, systems, and apparatus, including computer programs encoded on a computer storage medium, for generating data defining molecules. In one aspect, there is provided a method performed by one or more computers, the method comprising: receiving, from a user, a request to generate data identifying candidate molecules satisfying one or more molecular criteria; generating a collection of candidate molecules that satisfy the one or more molecular criteria; generating, for each candidate molecule in the collection of candidate molecules, one or more molecular scores that characterize one or more properties of the candidate molecule; filtering the collection of candidate molecules, based on the molecular scores, to remove a plurality of candidate molecules from the collection of candidate molecules; and after filtering the collection of candidate molecules based on the molecular scores, providing a representation of the collection of candidate molecules to the user.
    Type: Grant
    Filed: January 9, 2024
    Date of Patent: December 3, 2024
    Assignee: Genesis Therapeutics, Inc.
    Inventors: Ben Sklaroff, Matteus Jiawei Pan, Korrawat Pruegsanusak, Alexander Upjohn Beatson, Zachary Joseph Kagin, Wojciech Piotr Swiderski, Euxhen Hasanaj, Kenneth Knute Leidal, Anders Joseph Papitto, Maruan Al-Shedivat
  • Patent number: 12043673
    Abstract: The compositions and methods provide herein include, inter alia, antibodies attached to single-stranded oligoribonucleotides. Two antibodies are capable of forming complexes in vivo through hybridization of the respective complementary oligoribonucleotides they are bound to. For example, a first antibody bound to a first oligoribonucleotide through a first chemical linker may be administered to a subject, bind to a cell surface antigen in vivo and subsequently form an antibody complex in vivo with a second antibody bound to a second oligoribonucleotide through a second chemical linker, through complementary base-pairing between the first and the second oligoribonucleotide. The compositions and methods provided herein are, inter alia, useful for diagnostic and therapeutic purposes, for example, the treatment of cancer or autoimmune disease.
    Type: Grant
    Filed: October 15, 2021
    Date of Patent: July 23, 2024
    Assignee: CITY OF HOPE
    Inventors: John E. Shively, Lin Li, Maciej Kujawski, Piotr Swiderski
  • Publication number: 20240233882
    Abstract: Methods, systems, and apparatus, including computer programs encoded on a computer storage medium, for generating data defining molecules. In one aspect, there is provided a method performed by one or more computers, the method comprising: receiving, from a user, a request to generate data identifying candidate molecules satisfying one or more molecular criteria; generating a collection of candidate molecules that satisfy the one or more molecular criteria; generating, for each candidate molecule in the collection of candidate molecules, one or more molecular scores that characterize one or more properties of the candidate molecule; filtering the collection of candidate molecules, based on the molecular scores, to remove a plurality of candidate molecules from the collection of candidate molecules; and after filtering the collection of candidate molecules based on the molecular scores, providing a representation of the collection of candidate molecules to the user.
    Type: Application
    Filed: January 9, 2024
    Publication date: July 11, 2024
    Inventors: Ben Sklaroff, Matteus Jiawei Pan, Korrawat Pruegsanusak, Alexander Upjohn Beatson, Zachary Joseph Kagin, Wojciech Piotr Swiderski, Euxhen Hasanaj, Kenneth Knute Leidal, Anders Joseph Papitto, Maruan Al-Shedivat
  • Publication number: 20240233880
    Abstract: Methods, systems, and apparatus, including computer programs encoded on a computer storage medium, for generating data defining molecules. In one aspect, there is provided a method comprising: receiving, from a user, data defining a chemical computation graph, wherein: the chemical computation graph comprises a set of chemical computation nodes and a set of edges; each chemical computation node is configured to perform operations comprising: receiving a set of input molecules; and processing the set of input molecules, in accordance with a sequence of one or more transformation operations associated with the chemical computation node, to generate a set of output molecules; and each edge connects a respective first chemical computation node to a respective second chemical computation node; and generating a set of candidate molecules using the chemical computation graph.
    Type: Application
    Filed: January 9, 2024
    Publication date: July 11, 2024
    Inventors: Ben Sklaroff, Matteus Jiawei Pan, Korrawat Pruegsanusak, Zachary Joseph Kagin, Wojciech Piotr Swiderski
  • Publication number: 20240104645
    Abstract: A method for identifying a set of optimized financing programs to provide to a merchant may include receiving historical loan application data defining historical parameters associated with corresponding historical loan applications, replacing at least a portion of the historical parameters of the historical loan application data with new parameters associated with different loan terms to define a simulated loan data set defining simulated financing programs, determining a selection probability score for each of the simulated financing programs, the selection probability score indicating a likelihood of customer selection of each respective one of the simulated financing programs, determining a cash flow rating for each of the simulated financing programs, the cash flow rating estimating cash flow over time for the each respective one of the simulated financing programs, determining a valuation score based on the selection probability score and the cash flow rating of the each respective one of the simulated
    Type: Application
    Filed: September 22, 2022
    Publication date: March 28, 2024
    Inventors: Hanif Leoputera, Adriel Sumathipala, Nelson Chen, Ting Chih Lin, Niloy Gupta, Wojciech Piotr Swiderski, Raghavendra Abhinay Korukonda, Isaac Joseph
  • Patent number: 11535847
    Abstract: Provided herein, inter alia, are double stranded oligonucleotide molecules and methods of making the molecules. The double stranded oligonucleotide molecules include a first oligonucleotide strand comprising a first nucleic acid sequence bound to a second nucleic acid sequence through a first spacer, wherein said second nucleic acid sequence is bound to a third nucleic acid sequence through a second spacer and a second oligonucleotide strand comprising a fourth nucleic acid sequence bound to a fifth nucleic acid sequence through a third spacer, wherein said fifth nucleic acid sequence is bound to a sixth nucleic acid sequence through a fourth spacer, wherein the second nucleic acid sequence and the fifth nucleic acid sequence are hybridized to form a double stranded nucleic acid core of said double stranded oligonucleotide.
    Type: Grant
    Filed: December 3, 2019
    Date of Patent: December 27, 2022
    Assignee: CITY OF HOPE
    Inventor: Piotr Swiderski
  • Publication number: 20220119552
    Abstract: The compositions and methods provide herein include, inter alia, antibodies attached to single-stranded oligoribonucleotides. Two antibodies are capable of forming complexes in vivo through hybridization of the respective complementary oligoribonucleotides they are bound to. For example, a first antibody bound to a first oligoribonucleotide through a first chemical linker may be administered to a subject, bind to a cell surface antigen in vivo and subsequently form an antibody complex in vivo with a second antibody bound to a second oligoribonucleotide through a second chemical linker, through complementary base-pairing between the first and the second oligoribonucleotide. The compositions and methods provided herein are, inter alia, useful for diagnostic and therapeutic purposes, for example, the treatment of cancer or autoimmune disease.
    Type: Application
    Filed: October 15, 2021
    Publication date: April 21, 2022
    Inventors: John E. Shively, Lin Li, Maciej Kujawski, Piotr Swiderski
  • Publication number: 20200339984
    Abstract: Provided herein, inter alia, are double stranded oligonucleotide molecules and methods of making the molecules. The double stranded oligonucleotide molecules include a first oligonucleotide strand comprising a first nucleic acid sequence bound to a second nucleic acid sequence through a first spacer, wherein said second nucleic acid sequence is bound to a third nucleic acid sequence through a second spacer and a second oligonucleotide strand comprising a fourth nucleic acid sequence bound to a fifth nucleic acid sequence through a third spacer, wherein said fifth nucleic acid sequence is bound to a sixth nucleic acid sequence through a fourth spacer, wherein the second nucleic acid sequence and the fifth nucleic acid sequence are hybridized to form a double stranded nucleic acid core of said double stranded oligonucleotide.
    Type: Application
    Filed: December 3, 2019
    Publication date: October 29, 2020
    Inventor: Piotr Swiderski
  • Patent number: 10538761
    Abstract: Provided herein, inter alia, are double stranded oligonucleotide molecules and methods of making the molecules. The double stranded oligonucleotide molecules include a first oligonucleotide strand comprising a first nucleic acid sequence bound to a second nucleic acid sequence through a first spacer, wherein said second nucleic acid sequence is bound to a third nucleic acid sequence through a second spacer and a second oligonucleotide strand comprising a fourth nucleic acid sequence bound to a fifth nucleic acid sequence through a third spacer, wherein said fifth nucleic acid sequence is bound to a sixth nucleic acid sequence through a fourth spacer, wherein the second nucleic acid sequence and the fifth nucleic acid sequence are hybridized to form a double stranded nucleic acid core of said double stranded oligonucleotide.
    Type: Grant
    Filed: July 13, 2016
    Date of Patent: January 21, 2020
    Assignee: City of Hope
    Inventor: Piotr Swiderski
  • Publication number: 20170029816
    Abstract: Provided herein, inter alia, are double stranded oligonucleotide molecules and methods of making the molecules. The double stranded oligonucleotide molecules include a first oligonucleotide strand comprising a first nucleic acid sequence bound to a second nucleic acid sequence through a first spacer, wherein said second nucleic acid sequence is bound to a third nucleic acid sequence through a second spacer and a second oligonucleotide strand comprising a fourth nucleic acid sequence bound to a fifth nucleic acid sequence through a third spacer, wherein said fifth nucleic acid sequence is bound to a sixth nucleic acid sequence through a fourth spacer, wherein the second nucleic acid sequence and the fifth nucleic acid sequence are hybridized to form a double stranded nucleic acid core of said double stranded oligonucleotide.
    Type: Application
    Filed: July 13, 2016
    Publication date: February 2, 2017
    Applicant: City of Hope
    Inventor: Piotr Swiderski